Huber Gerhard F, Dziegielewski Peter, Matthews T Wayne, Warshawski S Joseph, Kmet Leanne M, Faris Peter, Khalil Moosa, Dort Joseph C
Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Calgary Health Region, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada.
Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):874-81. doi: 10.1001/archotol.133.9.874.
To determine accuracy and intertest agreement of preoperative fine-needle aspiration cytology (FNAC) and intraoperative frozen-section analysis (FS) findings in thyroid surgery, and to assess the influence of intraoperative FS findings on decision making and the utility of FS in thyroid surgery.
Retrospective analysis. The results of preoperative FNAC, intraoperative FS, and final histopathological analyses were taken from the histopathology reports. We calculated intertest agreement using the kappa statistic.
Two-hundred fifteen patients who underwent primary thyroid surgery. All patients were treated by the same surgeon (S.J.W.).
T he sensitivity and specificity of FNAC were 57.4% and 91.7%, respectively. The sensitivity and specificity of FS were 32.4% and 96.5%, respectively. The intertest agreement was poor (kappa = 0.17). In case of malignant FNAC findings, the FS result did not influence treatment decisions; in case of a malignant FS result on the background of a benign, indeterminate, or nondiagnostic FNAC finding, the FS result influenced treatment decisions in 88% of cases.
Intraoperative FS did not give additional information in cases where a malignant neoplasm was predicted by the FNAC finding. In this setting, it led to conflicting results and did not contribute to correct decision making.
确定甲状腺手术中术前细针穿刺细胞学检查(FNAC)和术中冰冻切片分析(FS)结果的准确性及检验间一致性,并评估术中FS结果对决策的影响以及FS在甲状腺手术中的实用性。
回顾性分析。术前FNAC、术中FS及最终组织病理学分析结果均取自组织病理学报告。我们使用kappa统计量计算检验间一致性。
215例行原发性甲状腺手术的患者。所有患者均由同一位外科医生(S.J.W.)治疗。
FNAC的敏感性和特异性分别为57.4%和91.7%。FS的敏感性和特异性分别为32.4%和96.5%。检验间一致性较差(kappa = 0.17)。若FNAC结果为恶性,FS结果不影响治疗决策;若在FNAC结果为良性、不确定或无法诊断的背景下FS结果为恶性,FS结果在88%的病例中影响治疗决策。
在FNAC结果预测为恶性肿瘤的情况下,术中FS未提供额外信息。在此情况下,它导致结果相互矛盾,无助于做出正确决策。